Related references
Note: Only part of the references are listed.Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy
Gabriela Khoury et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy
James I. Mullins et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T. Gandhi et al.
PLOS PATHOGENS (2017)
Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome
Roos M. van der Vuurst de Vries et al.
JAMA NEUROLOGY (2017)
Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy
Sharon A. Riddler et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
Sam Nightingale et al.
JOURNAL OF NEUROVIROLOGY (2016)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo et al.
NATURE (2016)
Neopterin and Soluble CD14 Levels as Indicators of Immune Activation in Cases with Indeterminate Pattern and True Positive HIV-1 Infection
Hayriye Kirkoyun Uysal et al.
PLOS ONE (2016)
Immune activation and HIV: an enduring relationship
Irini Sereti et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Persistent HIV-1 replication during antiretroviral therapy
Javier Martinez-Picado et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo
Reinhart Speeckaert et al.
JAMA DERMATOLOGY (2016)
Data on pro-inflammatory cytokines IL-1β, IL-17, and IL-6 in the peripheral blood of HIV-infected individuals
Tommy Saing et al.
DATA IN BRIEF (2016)
Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study
Alison G. Abraham et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Factors Associated With Plasma IL-6 Levels During HIV Infection
Alvaro H. Borges et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Changes in HIV reservoirs during long-term antiretroviral therapy
Feiyu F. Hong et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
Rongfen Gao et al.
BIOMED RESEARCH INTERNATIONAL (2015)
During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ
Alessandra Ruggiero et al.
EBIOMEDICINE (2015)
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy
Guillaume J. Besson et al.
CLINICAL INFECTIOUS DISEASES (2014)
CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells
Leslie R. Cockerham et al.
PLOS ONE (2014)
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Courtney V. Fletcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Dynamics of Cellular HIV-1 DNA Levels Over 144 Weeks of Darunavir/Ritonavir Monotherapy Versus Triple Therapy in the MONET Trial
Anna Maria Geretti et al.
HIV CLINICAL TRIALS (2013)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt et al.
IMMUNOLOGICAL REVIEWS (2013)
Soluble CD27-Pool in Humans May Contribute to T Cell Activation and Tumor Immunity
Jianping Huang et al.
JOURNAL OF IMMUNOLOGY (2013)
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T cells
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Highly Precise Measurement of HIV DNA by Droplet Digital PCR
Matthew C. Strain et al.
PLOS ONE (2013)
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time
Lina Josefsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immune activation and HIV persistence: considerations for novel therapeutic interventions
Hiroyu Hatano
CURRENT OPINION IN HIV AND AIDS (2013)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson et al.
PLOS PATHOGENS (2013)
Plasma HIV-1 RNA Detection Below 50 Copies/mL and Risk of Virologic Rebound in Patients Receiving Highly Active Antiretroviral Therapy
Tomas Doyle et al.
CLINICAL INFECTIOUS DISEASES (2012)
Low-level viraemia on HAART: significance and management
Tomas Doyle et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals
Julia Poeta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy
Mark A. Wallet et al.
AIDS (2010)
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study
Catia Marzolini et al.
ANTIVIRAL THERAPY (2010)
Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology
Martijn A. Nolte et al.
IMMUNOLOGICAL REVIEWS (2009)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia
Frank Maldarelli et al.
PLOS PATHOGENS (2007)
CD27-CD70 interactions sensitise naive CD4(+) T cells for IL-12-induced T(h)1 cell development
Michiel F. van Osterk et al.
INTERNATIONAL IMMUNOLOGY (2007)
Effects of potent Antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D
A Atlas et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Human immunodeficiency virus cDNA metabolism: Notable stability of two-long terminal repeat circles
SL Butler et al.
JOURNAL OF VIROLOGY (2002)
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication
TC Pierson et al.
JOURNAL OF VIROLOGY (2002)
Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects
A De Milito et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
ME Sharkey et al.
NATURE MEDICINE (2000)
Share Paper
